A399D (p.Ala399Asp) variant of LDLR (Low-density lipoprotein receptor)
A399D (p.Ala399Asp) in LDLR (Low-density lipoprotein receptor) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Hypercholesterolemia, familial, 1. The available variant effect predictions contribute to a CATVariant prioritization score of 0.67 / 1. The record also includes population frequency data, published literature, and structural context.
A399D (p.Ala399Asp) variant details
- p.Ala399Asp
- rs875989918
- ClinGen CA10576301
- ClinVar RCV000211653
- ClinVar RCV001249013
- Likely pathogenic
- Hypercholesterolemia, familial, 1
- Missense
- Variant Prioritization Score for Impact Estimate 0.666
- CADD 24.40
- PolyPhen-2 0.81
- SIFT 0.00
- ClinVar: Likely pathogenic (Hypercholesterolemia, familial, 1)
- EBI: Pathogenic (in FHCL1)
- UniProt: Pathogenic (in FHCL1)
- Most common in the Non-Finnish European population (allele frequency 1.6e-05)
- Structural context available
- Cited in: Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. (PMID 9259195)
- Cited in: Familial Hypercholesterolemia. (PMID 24404629)